Baran Seven | Biology and Life Sciences | Best Academic Researcher Award

Published on by Research Hypothesis

Dr. Baran Seven | Biology and Life Sciences | Best Academic Researcher Award

TST Rakor ve Tıbbi Aletler San ve Tic Ltd Sti | Turkey 

Dr. Baran Seven is a dedicated academic researcher in the field of Biology, specializing in toxicology, genotoxicity, and environmental health sciences. He completed his Ph.D. in Biology at Giresun University in 2022, following both his bachelor’s and master’s degrees from the same institution. His research primarily focuses on investigating the toxic effects of various environmental and chemical agents—such as pesticides, parabens, heavy metals, and synthetic additives—using in vivo models like Swiss albino mice and Allium cepa. He also explores the protective roles of natural plant extracts (e.g., grape seed, Nigella sativa, and nettle) against induced toxicity. Dr. Seven has contributed to numerous peer-reviewed national and international publications, including a notable article in Scientific Reports, and has presented at more than 25 scientific conferences. With experience in collaborative research projects and a consistent academic trajectory, he is emerging as a strong researcher in the field of experimental biology and environmental toxicology.

Professional Profile 

Scopus Profile

Education 

Dr. Baran Seven has pursued his entire academic journey in the field of Biology at Giresun University, Turkey. He earned his Bachelor’s degree in Biology in 2013, laying a solid foundation in life sciences. He then completed his Master’s degree in 2015, focusing on toxicology with a thesis titled “Albino farelerde paraben tarafından teşvik edilen toksisiteye karşı ısırgan otu özütünün koruyucu rolünün araştırılması” (The protective role of nettle extract against paraben-induced toxicity in albino mice). Building on this expertise, he obtained his Ph.D. in Biology in 2022, with a comprehensive dissertation titled “Swiss albino farelerde sipermetrin toksisitesinin araştırılması: Fizyolojik, genetik ve biyokimyasal yaklaşım” (Investigation of cypermethrin toxicity in Swiss albino mice: A physiological, genetic, and biochemical approach). His academic progression reflects a strong and focused commitment to experimental toxicology and environmental biology.

Professional Experience 

Dr. Baran Seven has cultivated significant research experience in the fields of environmental toxicology, genotoxicity, and biological sciences through his active involvement in various academic projects and collaborative studies. He has served as a research assistant and co-investigator in multiple experimental research projects focusing on the physiological and genotoxic impacts of chemical substances—including parabens, lead, titanium dioxide, and pesticides—on animal and plant models. His work notably includes assessing the protective effects of natural compounds like Nigella sativa, carotene, and grape seed extract against chemically induced toxicity. In addition to project-based roles, Dr. Seven has contributed extensively to academic literature with research published in peer-reviewed journals and numerous presentations at national and international scientific conferences. His hands-on involvement in laboratory experiments and interdisciplinary teamwork highlights his strong technical skills and dedication to advancing public health-related biological research.

Research Interests 

Dr. Baran Seven’s research interests lie at the intersection of environmental toxicology, genotoxicity, and natural product pharmacology. He is particularly focused on exploring the toxic effects of environmental pollutants—such as pesticides (e.g., cypermethrin), heavy metals, and industrial chemicals—on living organisms, using both animal (Mus musculus) and plant (Allium cepa) model systems. A significant aspect of his work involves evaluating the protective and therapeutic potential of natural plant extracts (like Urtica dioica, Nigella sativa, and grape seed extract) against chemically induced oxidative stress and DNA damage. His multidisciplinary approach combines physiological, biochemical, and genetic analysis techniques, including the Comet assay and chromosomal aberration tests, to assess cellular responses to toxic exposure. Dr. Seven’s work aims to contribute to environmental health, public safety, and the development of natural alternatives to chemical-based interventions.

Awards and Honors 

While specific individual awards and honors are not explicitly listed in his academic record, Dr. Baran Seven’s scholarly contributions have been consistently recognized through his active participation in national and international scientific congresses, where he has presented numerous full-text papers and oral/poster presentations. His research has earned visibility in prestigious platforms such as the Scientific Reports journal, reflecting the academic merit and impact of his work in the field of toxicology and genotoxicology. His selection as a co-author and contributor in multiple collaborative projects also indicates the professional respect and trust he holds within his research community. Continued recognition through peer-reviewed publications and invitations to present at major scientific forums highlight his growing reputation as a promising researcher in environmental health and biological sciences.

Publications Top Noted

Title: Investigation of cypermethrin toxicity in Swiss albino mice with physiological, genetic and biochemical approaches

Year: 2022

Citations: 25

Conclusion

Dr. Baran Seven demonstrates strong potential and suitability for the Best Academic Researcher Award, particularly in the early-career or mid-career researcher category (age 34). His focused and original contributions to toxicology and genotoxicity, consistent publication record, and active conference engagement qualify him for recognition.

Hiranmoy Das | Biology and Life Sciences | Lifetime achievement Award

Published on by Research Hypothesis

Hiranmoy Das | Biology and Life Sciences | Lifetime achievement Award

Prof Hiranmoy Das, Texas Tech University Health Sciences Center, United States

Prof. Hiranmoy Das, MSc, PhD, FAHA, is a renowned biochemist and pharmacologist with a distinguished career. He holds a Ph.D. from the University of Calcutta and has postdoctoral training from prestigious institutions like Harvard Medical School and the Hyogo Institute of Clinical Research. Currently a Professor at Texas Tech University, his research focuses on cardiovascular stem cell therapies, regenerative medicine, and immunology. He has received numerous awards, including induction into the National Academy of Inventors and the American Heart Association. Prof. Das has authored several publications and holds multiple patents. 🌟📚💉🔬🧬

Publication Profile

Google Scholar

Education

Prof. Hiranmoy Das holds a Ph.D. in Biochemistry from the University of Calcutta (1995) and has extensive academic training in zoology, advanced cytogenetics, immunology, and biology. He completed postdoctoral fellowships at prestigious institutions, including Harvard Medical School (1999-2002) and Hyogo Institute of Clinical Research, Japan (1996-1999). Prof. Das has held prominent roles, such as Professor at Texas Tech University (2016-present) and Associate Professor at The Ohio State University (2008-2016). He also directed cardiovascular stem cell research laboratories. His remarkable career spans over decades, focusing on innovative research in the fields of biochemistry and immunology. 📚💉🔬

Honors and Awards

Prof. Hiranmoy Das, a distinguished researcher and educator, has received numerous accolades for his groundbreaking contributions. In 2024, he was elected as a Fellow of the National Academy of Inventors. He was inducted into the prestigious Sigma Xi in 2023 and awarded the President’s Excellence in Research Award in 2022. As a tenured professor at Texas Tech University, he earned the Chancellor’s Council Distinguished Research Award in 2021. His honors also include the American Heart Association Fellowship (2021) and a Keynote Speaker role at an International Conference in 2018. Earlier awards include the NIH K01 Award and National Merit Scholarship. 🏆🔬🎓

Experiences

Prof. Hiranmoy Das has taught a variety of undergraduate, graduate, and professional courses at TTUHSC, including leadership roles in Pharmaceutical Sciences Research (G) in Spring, Summer, and Fall sessions from 2021 to 2024 📚. He led courses like Clinical Correlation-6 and Integrated Therapy and Practice VII, as well as Experimental Design and Biostatistics 🧪. Prof. Das has mentored students in clinical and research settings, contributing significantly to pharmaceutical education 💡. His commitment to fostering academic growth is reflected in his continued leadership in research-focused courses, impacting future professionals in the field of pharmaceutical sciences 🎓.

PhD Thesis

Prof. Hiranmoy Das appears to be heavily involved in mentoring and advising graduate students, particularly in the fields related to pharmacy, veterinary medicine, and health sciences. His research likely focuses on advanced pharmaceutical sciences, drug development, and therapeutics. With his role in advising students pursuing PhD and MS theses, his research could be centered around pharmaceutical applications, medicinal chemistry, or pharmacology. Given his involvement in both veterinary and pharmacy programs, his research may also bridge the gap between human and veterinary health, focusing on biomedical sciences, drug formulations, and therapeutics for both sectors. 📚💊🐾👩‍🔬👨‍🔬

Research Focus

Hiranmoy Das focuses on molecular and cellular biology, particularly related to vascular biology, immunology, and inflammation. His research delves into the roles of Kruppel-like factor 2 (KLF2) in endothelial cells, immune responses, and its regulatory functions in cardiovascular health. He also investigates autophagy, cell death, and ischemic stroke therapies, emphasizing the use of assays for monitoring these processes. His work highlights the role of phytochemicals in cancer prevention and the immune system’s effector functions. Das has made significant contributions to understanding cellular signaling and disease mechanisms, with implications for therapeutic development. 🔬💉🧬🫀

Publication Profile

Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)1

Guidelines for the use and interpretation of assays for monitoring autophagy in higher eukaryotes

Guidelines for the use and interpretation of assays for monitoring cell death in higher eukaryotes

Current advances in ischemic stroke research and therapies

MICA engagement by human Vγ2Vδ2 T cells enhances their antigen-dependent effector function

Kruppel-like factor 2 as a novel mediator of statin effects in endothelial cells

Kruppel-like factor 2 (KLF2) regulates proinflammatory activation of monocytes

CD1-mediated γ/δ T cell maturation of dendritic cells